Editorial: Noninvasive tests for metabolic dysfunction-associated steatotic liver disease: A refinement of the Nash-FibroTest for type 2 diabetes mellitus

Aliment Pharmacol Ther. 2023 Nov;58(10):1111-1112. doi: 10.1111/apt.17706.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / diagnosis
  • Humans
  • Non-alcoholic Fatty Liver Disease* / diagnosis